Hyperandrogenism in Women: Polycystic Ovary Syndrome

    January 2012 in “ Hanyang Medical Reviews ”
    Yeon Ah Sung
    Image of study
    TLDR The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.
    The document from 2012 reviewed hyperandrogenism in women, with a focus on polycystic ovary syndrome (PCOS), which affects 4 to 8% of premenopausal women and is characterized by symptoms like hirsutism, acne, and androgenetic alopecia. It discussed the pathogenesis of hirsutism, clinical and biochemical features for therapeutic decisions, and diagnostic criteria for PCOS, emphasizing the need for criteria tailored to Korean women due to reproductive and metabolic complications associated with the syndrome. The review included an analysis of 2,950 premenopausal Korean women, finding the prevalence of PCOS consistent with other populations. It concluded that further research is necessary to establish appropriate diagnostic criteria and understand the clinical features and progression of PCOS in Korean women. Additionally, it referenced a genetic study identifying a novel SNP, rs4745427, associated with PCOS in the Korean population, indicating the potential for personalized medicine based on genetics.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 7 results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Related Research

    3 / 3 results